Cysteine specific bioconjugation with benzyl isothiocyanates

Area of Science:

• Medicinal Chemistry
• Chemical Biology
• Bioconjugation

Background:

• Protein labeling is crucial for drug discovery, target validation, and diagnostics.
• Fluorescent dyes are essential tools for visualizing and studying biomolecules.
• Existing labeling agents like fluorescein isothiocyanate have limitations.

Purpose of the Study:

• To develop a novel, improved fluorescent dye for protein labeling.
• To evaluate the reactivity and selectivity of a new benzyl-isothiocyanate-based dye.
• To demonstrate specific labeling of clinically relevant proteins like trastuzumab.

Main Methods:

• Fragment-based development of a benzyl-isothiocyanate-activated fluorescein dye.
• Comparative analysis of phenyl- and benzyl isothiocyanate reactivity at varying pH.
• In vitro testing of dye activity on diverse protein targets.
• Specific labeling of trastuzumab and its Fab fragment via cysteine residues.

Main Results:

• The newly developed benzyl-fluorescein isothiocyanate exhibits favorable reactivity and selectivity.
• Optimized labeling protocols were established for efficient protein conjugation.
• Successful and specific labeling of the antibody trastuzumab was achieved.
• The new dye offers a valuable alternative to existing labeling agents.

Conclusions:

• The developed benzyl-fluorescein isothiocyanate represents a significant advancement in fluorescent labeling technology.
• This novel dye and its optimized protocol enhance capabilities in chemical biology and diagnostics.
• The findings provide a versatile tool for researchers in drug discovery and biomolecular studies.